Abstract Submission

Call for abstracts

We are delighted to announce the Call for Abstracts for the SIGN 2024 Conference, taking place in Hyderabad, India from January 5th to 7th, 2024. It will be highly interdisciplinary event, featuring prominent contributors from a wide range of fields crucial to advancing neurointerventions, including clinical medicine, basic science, engineering and computing. Our goal is to foster collaboration and innovation by breaking down silos and crossing boundaries that often separate us in our respective fields. Although the conference has a neurointerventional focus, we welcome submissions and attendance from clinicians and scientists across all related disciplines. Neurointerventions are meant very broadly including molecular aspects of modulation and modification of the central nervous system in physiological and pathological states.

We are proud to have secured outstanding speakers and panelists for the program, and we have reserved ample slots for the best scoring abstracts. We encourage submissions to compete for Invited Talks: to be considered as a speaker for the main program, abstracts must be submitted before the deadline on July 15, at 5pm EST 2023. Notifications for those selected for invited talks will be sent out by August 15, 2023. Abstracts not selected for invited talks will be automatically transferred to the pool for general submission.

General abstract submission is open until September 1 2023, and welcome abstracts for paper or electronic poster presentations. Notifications of acceptance will be send out by September 15, 2023.

Gullapalli Young Investigator Awards: All young investigators (see criteria below), submitting abstracts in the general abstract submission should indicate their interest in competing for a Gullapalli Young Investigator Award (three awards will be given this year). These awards are established in memoriam of Rao Gullapalli, a great leader and mentor who made significant contributions to various fields of Radiology, image guided interventions and TBI, among others. Dr. Gullapalli recently served as a Vice-Chair for Research in the Department of Diagnostic Radiology and Nuclear Medicine at the University of Maryland School of Medicine in Baltimore, USA. He has been avidly involved in organizing SIGN 2024 in Hyderabad, and his premature death in the middle of work struck all of us, therefore it is important to recognize his contributions also to SIGN conferences.

Join us at the SIGN 2024 Conference for an exciting and collaborative exploration of the latest advances in neurointerventions!

Abstract submission guidelines

All abstracts must be submitted in English.
Do not include the name or personal information of any patient participating in the study or trial.
Recommended subsections included in the abstracts: Objectives and Hypothesis, Methods, Findings, and Conclusions.
We accept jpg and pdf file for figure upload.
The submitted abstracts will be evaluated and scored by experts. Acceptance letters will be sent by email.
Presenters who meet eligibility criteria are encouraged to compete for Gullapalli Young Investigator Award (see below).
In addition, we will give out a number of travel awards based on merit reflected by a score pending availability of funds.

Gullapalli Young Investigator Award Eligibility Criteria

Candidates must be in training or have completed training no more than seven years ago. Training is defined as any post-graduate training (medical science, engineering, computing, basic science).
Candidates may be from any country.
Candidates may be from any field of research or clinical practice.
Candidates must submit an abstract as the first author to the SIGN Annual Conference.
Candidates must have primarily conducted the research presented in the abstract.
Awardees may be asked to write a brief report after the Conference and to complete a short post-meeting evaluation.
Awardee must available at the award receiving ceremony.
Three prizes will be awarded.